Regenxbio Inc (RGNX)
16.06
+0.62
(+4.02%)
USD |
NASDAQ |
May 13, 11:39
Regenxbio Price: 16.06 for May 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 15.96 | 16.42 | 14.87 | 15.44 | 419972.0 |
May 09, 2024 | 16.55 | 16.64 | 15.56 | 15.68 | 498760.0 |
May 08, 2024 | 16.70 | 17.35 | 16.20 | 16.67 | 326247.0 |
May 07, 2024 | 16.93 | 17.15 | 16.31 | 16.96 | 402106.0 |
May 06, 2024 | 16.90 | 17.03 | 16.53 | 16.87 | 224712.0 |
May 03, 2024 | 17.24 | 17.52 | 16.68 | 16.83 | 239865.0 |
May 02, 2024 | 16.33 | 16.79 | 16.02 | 16.64 | 389117.0 |
May 01, 2024 | 15.43 | 17.00 | 15.27 | 16.20 | 482307.0 |
Apr 30, 2024 | 15.79 | 16.01 | 15.33 | 15.35 | 364815.0 |
Apr 29, 2024 | 16.24 | 16.80 | 15.95 | 16.05 | 294305.0 |
Apr 26, 2024 | 16.20 | 16.45 | 15.72 | 16.19 | 305658.0 |
Apr 25, 2024 | 15.80 | 16.16 | 15.29 | 16.06 | 604238.0 |
Apr 24, 2024 | 15.96 | 16.66 | 15.60 | 16.04 | 425390.0 |
Apr 23, 2024 | 15.67 | 16.28 | 15.52 | 15.90 | 360158.0 |
Apr 22, 2024 | 15.89 | 16.10 | 15.18 | 15.64 | 437246.0 |
Apr 19, 2024 | 16.01 | 16.26 | 15.32 | 15.69 | 574896.0 |
Apr 18, 2024 | 16.75 | 16.82 | 16.05 | 16.11 | 560518.0 |
Apr 17, 2024 | 17.59 | 17.99 | 16.99 | 17.03 | 413623.0 |
Apr 16, 2024 | 17.83 | 18.24 | 17.48 | 17.50 | 295968.0 |
Apr 15, 2024 | 18.07 | 18.65 | 17.82 | 18.02 | 346015.0 |
Apr 12, 2024 | 19.02 | 19.38 | 17.63 | 18.09 | 542760.0 |
Apr 11, 2024 | 19.12 | 19.12 | 18.48 | 19.02 | 362281.0 |
Apr 10, 2024 | 18.14 | 19.09 | 18.14 | 18.85 | 606178.0 |
Apr 09, 2024 | 19.20 | 19.77 | 18.73 | 19.01 | 266157.0 |
Apr 08, 2024 | 19.22 | 19.42 | 18.79 | 19.19 | 288378.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
12.17
Minimum
Jan 30 2024
54.20
Maximum
Feb 13 2020
30.44
Average
31.14
Median
Price Benchmarks
Sarepta Therapeutics Inc | 129.94 |
AbbVie Inc | 162.02 |
PTC Therapeutics Inc | 32.25 |
Edgewise Therapeutics Inc | 17.97 |
Catalyst Pharmaceuticals Inc | 16.11 |
Price Related Metrics
PS Ratio | 8.204 |
Price to Book Value | 2.025 |
Earnings Yield | -36.55% |
Market Cap | 791.05M |